Cancer Risk in Women Using the Levonorgestrel-Releasing Intrauterine System in Finland

Reproductive Factors, Exogenous Hormones, and Pancreatic Cancer Risk in the CTS

(2013) E. Lee et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Prediction of Regression and Relapse of Endometrial Hyperplasia With Conservative Therapy

(2013) Ioannis D. Gallos et al.   OBSTETRICS AND GYNECOLOGY

Tracking progesterone receptor-mediated actions in breast cancer

(2013) Todd P. Knutson et al.   PHARMACOLOGY & THERAPEUTICS

Estrogenic Steroid Hormones in Lung Cancer

(2013) Jill M. Siegfried et al.   SEMINARS IN ONCOLOGY

Quality of the Finnish Hospital Discharge Register: A systematic review

(2012) Reijo Sund   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer

(2011) Jürgen Dinger et al.   CONTRACEPTION

Progesterone: the ultimate endometrial tumor suppressor

(2011) Shujie Yang et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Endometrial cancer associated with various forms of postmenopausal hormone therapy: A case control study

(2010) Susanna Jaakkola et al.   INTERNATIONAL JOURNAL OF CANCER

A case-control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well

(2009) Heli K. Lyytinen et al.   INTERNATIONAL JOURNAL OF CANCER

Progestogen deficiency and endometrial cancer risk

(2009) Adolf E. Schindler   MATURITAS

Meta-Analysis of Intrauterine Device Use and Risk of Endometrial Cancer

(2008) Robin M. Beining et al.   ANNALS OF EPIDEMIOLOGY

Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus

(2008) Yasemin Tasci et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

The cell of origin of ovarian epithelial tumours

(2008) Louis Dubeau   LANCET ONCOLOGY